Immunome Shares Are Trading Higher After a Form4 Filing Showed President and CEO Clay Siegall Bought 100,000 Shares at an Average Price of $13.88 per Share.
Immunome Shares Are Trading Higher After a Form4 Filing Showed President and CEO Clay Siegall Bought 100,000 Shares at an Average Price of $13.88 per Share.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.